Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".

More about this publication

International journal of cancer
  • Publication date 20-07-2022

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.